ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustrySt-Sulpice VdHemostOD SA
HemostOD SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of HemostOD is the development and manufacture of universal, genetically modified platelets (thrombocytes) for medical applications, including the treatment of thrombocytopenia, targeted delivery of active substances to specific tissues, and applications in regenerative medicine and the culture of therapeutic stem cells.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

HemostOD SA

✓ Offered6
Platform for the production of universal platelets
Platform for the development and manufacturing of universal, HLA-low platelets from proprietary cell and microfluidics technology.
Development of therapies for thrombocytopenia
Development of universal platelets for the treatment of patients with, or at risk of, HLA immune refractoriness.
Tissue-targeted cargo delivery with CAR-PLT™
Protected delivery of miRNA/siRNA or proteins to specific target tissues using the CAR-PLT™ technology.
Applications for regenerative medicine
Use of engineered platelets in wound healing, anti-inflammatory and immunomodulating applications.
Culture of therapeutic stem cells
Use of platelet lysate from universal platelets to promote cell proliferation.
Partnerships for preclinical platelet development
Cooperations and partnering for thrombocytopenia, CAR-PLT™ cargo delivery, regenerative medicine and platelet-lysate-based cell culture.
Trust & reputation

ranQ Trust Score of HemostOD SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

HemostOD SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
HemostOD SA scores 76.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
HemostOD SA scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
HemostOD SA scores 28.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.28.64%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

HemostOD SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once HemostOD SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

HemostOD SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank HemostOD SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of HemostOD SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Rue des Jordils 1 a
1025 St-Sulpice Vd

At a glance

Legal form
Corporation
UID
CHE-278.248.627
Founded
2020 · 6 years
Last commercial register change
July 16, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    NB
    Nagi Bioscience SA
    St-Sulpice Vd
    BS
    Bredam SA
    St-Sulpice Vd
    ST
    Synameta Therapeutics SARL
    Epalinges
    NS
    Novigenix SA
    Epalinges
    LS
    Limula SA
    La Tour-De-Peilz
    PS
    PeriVision SA
    Epalinges
    DS
    Débiotech S.A.
    Lausanne
    SG
    SOPHiA GENETICS SA
    Rolle